New Drug Development for Known and Emerging Viruses
8 Angebote vergleichen

Von Händler/Antiquariat, moluna [73551232], Greven, Germany.
Helga Ruebsamen-Schaeff, PhD, is founding CEO of AiCuris and the chair of AiCuris\ Scientific Advisory Board. Before founding AiCuris she served at Bayer as SVP and Head of Infectious Disease Research. Before that time, she was Scientific and Managing Direc. Books.

Lieferung aus: Deutschland, zzgl. Versandkosten.
Von Händler/Antiquariat, Moluna GmbH, [5901482].
Helga Ruebsamen-Schaeff, PhD, is founding CEO of AiCuris and the chair of AiCuris Scientific Advisory Board. Before founding AiCuris she served at Bayer as SV, 2021, Gebunden, Neuware, Hardcover, 1140g, 1. Auflage, 506, Banküberweisung, PayPal.

Lieferung aus: Deutschland, zzgl. Versandkosten.
Von Händler/Antiquariat, Buchbär, [6122477].
Discusses how to fight Ebola, SARS Corona, and other known or emerging human viruses by building on the successes in antiviral therapy of the past decades Written by leading medicinal chemists and virologists from academia and industry, this book discusses the entire field of antiviral drug discovery and development from a medicinal chemistry perspective, focusing on antiviral drugs, targets, and viral disease mechanisms. It provides an outlook on emerging pathogens such as Ebola, Zika, West Nile, Lassa, and includes a chapter on SARS Coronavirus-2 causing the present pandemic. 'New Drug Development for Known and Emerging Viruses' describes the discovery and development process of antiviral agents for different species of viruses and their targets based on the experiences from seven human viruses for which approved drugs are on the market (HIV, HCV, Influenza, RSV, HBV, HCMV, and HSV). It covers the properties and potential of currently approved antivirals, including combination... 2022, Gebunden, Neuware, 1076g, 506, Banküberweisung, PayPal, Klarna-Sofortüberweisung.

Lieferung aus: Deutschland, zzgl. Versandkosten.
Von Händler/Antiquariat, preigu, [5789586].
Discusses how to fight Ebola, SARS Corona, and other known or emerging human viruses by building on the successes in antiviral therapy of the past decades Written by leading medicinal chemists and virologists from academia and industry, this book discusses the entire field of antiviral drug discovery and development from a medicinal chemistry perspective, focusing on antiviral drugs, targets, and viral disease mechanisms. It provides an outlook on emerging pathogens such as Ebola, Zika, West Nile, Lassa, and includes a chapter on SARS Coronavirus-2 causing the present pandemic. 'New Drug Development for Known and Emerging Viruses' describes the discovery and development process of antiviral agents for different species of viruses and their targets based on the experiences from seven human viruses for which approved drugs are on the market (HIV, HCV, Influenza, RSV, HBV, HCMV, and HSV). It covers the properties and potential of currently approved antivirals, including combination... 2022, Gebunden, Neuware, 1076g, 506, Banküberweisung, PayPal, Klarna-Sofortüberweisung.

Lieferung aus: Deutschland, Versandkosten nach: Schweiz.
Von Händler/Antiquariat, Buchhandlung Kisch & Co. [3338288].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen

Lieferung aus: Deutschland, zzgl. Versandkosten.
Von Händler/Antiquariat, Buchhandlung - Bides GbR, [4124740].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen

Lieferung aus: Kanada, zzgl. Versandkosten.
New Drug Development For Known And Emerging Viruses.